ATE298562T1 - Hydrogelpartikel formulierungen - Google Patents

Hydrogelpartikel formulierungen

Info

Publication number
ATE298562T1
ATE298562T1 AT00901795T AT00901795T ATE298562T1 AT E298562 T1 ATE298562 T1 AT E298562T1 AT 00901795 T AT00901795 T AT 00901795T AT 00901795 T AT00901795 T AT 00901795T AT E298562 T1 ATE298562 T1 AT E298562T1
Authority
AT
Austria
Prior art keywords
methods
hydrogel particle
particle formulations
new compositions
compositions
Prior art date
Application number
AT00901795T
Other languages
English (en)
Inventor
Barbara H O'connor
Steven Joseph Prestrelski
Yuh-Fun Maa
Andrew Muddle
Roderick Hafner
Terry Lee Burkoth
Original Assignee
Powderject Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Res Ltd filed Critical Powderject Res Ltd
Application granted granted Critical
Publication of ATE298562T1 publication Critical patent/ATE298562T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00901795T 1999-02-03 2000-02-03 Hydrogelpartikel formulierungen ATE298562T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11833499P 1999-02-03 1999-02-03
PCT/GB2000/000349 WO2000045792A1 (en) 1999-02-03 2000-02-03 Hydrogel particle formulations

Publications (1)

Publication Number Publication Date
ATE298562T1 true ATE298562T1 (de) 2005-07-15

Family

ID=22377934

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00901795T ATE298562T1 (de) 1999-02-03 2000-02-03 Hydrogelpartikel formulierungen

Country Status (16)

Country Link
US (1) US7022313B2 (de)
EP (1) EP1146861B1 (de)
JP (1) JP2002536317A (de)
KR (1) KR100845769B1 (de)
CN (1) CN1230152C (de)
AT (1) ATE298562T1 (de)
AU (1) AU780397B2 (de)
BR (1) BR0007974A (de)
CA (1) CA2361555A1 (de)
DE (1) DE60021059T2 (de)
ES (1) ES2243229T3 (de)
IL (2) IL144597A0 (de)
MX (1) MXPA01007844A (de)
NZ (1) NZ513538A (de)
PT (1) PT1146861E (de)
WO (1) WO2000045792A1 (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1158961A1 (de) * 1999-03-08 2001-12-05 PowderJect Research Limited Verabreichung von mikroteilchen-formulierungen unter verwendung einer nadellosen spritze zur verzörgerten freigabe bioaktiver verbindungen
US20050214227A1 (en) * 1999-03-08 2005-09-29 Powderject Research Limited Microparticle formulations for sustained-release of bioactive compounds
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
KR100889069B1 (ko) 1999-10-29 2009-03-17 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
WO2002019989A2 (en) * 2000-09-08 2002-03-14 Powderject Research Limited Alginate particle formulation
AU2738302A (en) 2000-10-30 2002-05-15 Euro Celtique Sa Controlled release hydrocodone formulations
GB0103620D0 (en) * 2001-02-14 2001-03-28 Prometic Biosciences Ltd Sterile composition and its preparation
US7943067B2 (en) * 2001-08-16 2011-05-17 Polytechnic Institute Of New York University Nanogels and their production using liposomes as reactors
GB2379390B (en) * 2001-09-11 2005-01-26 Caretek Medical Ltd A novel drug delivery technology
AU2002346424A1 (en) * 2001-11-19 2003-06-10 Becton, Dickinson And Company Pharmaceutical compositions in particulate form
CN1308039C (zh) * 2002-04-10 2007-04-04 生命胶股份有限公司 多功能生物兼容的亲水性凝胶及其制备方法
EP1356826A1 (de) * 2002-04-22 2003-10-29 BIOMAY Produktions- und Handels- Aktiengesellschaft Mikropartikel die Kohlenhydratkugeln enthalten an welche ein Allergen kovalent gebunden sind
GB0300008D0 (en) * 2003-01-02 2003-02-05 Optinose As Delivery devices
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EP1697035B1 (de) * 2003-12-22 2017-11-15 Warren H. Finlay Pulverbildung durch atmosphärische sprühgefriertrocknung
ITRM20040168A1 (it) * 2004-04-01 2004-07-01 Sigma Tau Ind Farmaceuti Composizione a rilascio modificato ph dipendente.
KR100624450B1 (ko) * 2004-12-10 2006-09-18 삼성전자주식회사 히드로겔을 이용한 생물분자의 분리 및 정제 방법
KR100624452B1 (ko) * 2004-12-21 2006-09-18 삼성전자주식회사 고정화된 히드로겔 또는 ｐｅｇ－히드로겔 공중합체를이용한 핵산의 분리 및 정제 방법
NZ543314A (en) * 2005-10-28 2007-08-31 Interag A delivery system where the driving substance contains the active component
US10042980B2 (en) * 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US20070112592A1 (en) * 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Payments in providing assistance related to health
EP1981338A2 (de) * 2006-01-13 2008-10-22 Advanced Bionutrition Corporation Produktionssystem mit kontinuierlicher sprühnebelaufnahme
WO2007123793A2 (en) * 2006-04-04 2007-11-01 Stc.Unm Swellable particles for drug delivery
US20080069891A1 (en) 2006-09-15 2008-03-20 Cima Labs, Inc. Abuse resistant drug formulation
US8932634B2 (en) * 2006-06-15 2015-01-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Hydrocolloid carrier beads with inert filler material
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
JP2008096503A (ja) * 2006-10-06 2008-04-24 Toshiba Corp 粉末状感光性組成物の製造方法、感光性組成物およびこの感光性組成物から形成された光記録媒体
CN101861311A (zh) 2007-07-21 2010-10-13 阿尔巴尼分子研究公司 5-吡啶酮取代的吲唑
US8093038B2 (en) * 2007-09-17 2012-01-10 Illinois Institute Of Technology Apparatus and method for encapsulating pancreatic cells
US9468607B2 (en) * 2007-10-09 2016-10-18 Washington University Ligand directed toroidal nanoparticles for therapy and diagnostic imaging
CN101868180A (zh) 2007-10-09 2010-10-20 圣路易斯华盛顿州立大学 成像粒子
US8293510B2 (en) * 2007-11-16 2012-10-23 University Of Kansas Method of preparing a hydrogel network encapsulating cells
JP2011504505A (ja) 2007-11-21 2011-02-10 デコード ジェネティクス イーエイチエフ 肺および心血管障害を治療するためのビアリールｐｄｅ４抑制剤
KR101614723B1 (ko) 2008-01-11 2016-04-22 알바니 몰레큘라 리써치, 인크. Ｍｃｈ 길항물질로서 (1-아지논)-치환된 피리도인돌
WO2009108760A2 (en) 2008-02-26 2009-09-03 Board Of Regents, The University Of Texas System Dendritic macroporous hydrogels prepared by crystal templating
CN101959527B (zh) * 2008-03-05 2016-04-20 赛诺菲巴斯德有限公司 一种使含佐剂的疫苗组合物稳定的方法
WO2010059836A1 (en) 2008-11-20 2010-05-27 Decode Genetics Ehf Substituted aza-bridged bicyclics for cardiovascular and cns disease
KR20150116466A (ko) 2009-01-26 2015-10-15 이스라엘 인스티튜트 포 바이올로지컬 리서치 이환형 헤테로사이클릭 스피로 화합물
WO2010123798A2 (en) * 2009-04-20 2010-10-28 Galenbio, Inc. Compositions for transfection of biomolecules into cells
CA3149284A1 (en) 2009-12-15 2011-07-14 Incept, Llc Implants and biodegradable fiducial markers
US9764043B2 (en) 2009-12-17 2017-09-19 Washington University Antithrombotic nanoparticle
US9808500B2 (en) 2009-12-17 2017-11-07 Washington University Antithrombotic nanoparticle
EP2525815B1 (de) * 2010-01-24 2015-02-25 Novartis AG Bestrahlte bioabbaubare polymermikropartikeln
CN103096874A (zh) 2010-04-15 2013-05-08 华盛顿大学 前药组合物、前药纳米粒子及其使用方法
CA2798702A1 (en) 2010-05-11 2011-11-17 Cima Labs Inc. Alcoholresistant metoprolol-containing extended-release oral dosage forms
WO2012048289A1 (en) 2010-10-08 2012-04-12 Board Of Regents, The University Of Texas System Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
WO2012048283A1 (en) 2010-10-08 2012-04-12 Board Of Regents, The University Of Texas System One-step processing of hydrogels for mechanically robust and chemically desired features
CN103167868B (zh) * 2010-10-14 2016-08-03 株式会社爱茉莉太平洋 包覆有脂质的水凝胶粒子及其制备方法
US10092660B2 (en) * 2011-04-25 2018-10-09 Stc.Unm Solid compositions for pharmaceutical use
KR101255520B1 (ko) * 2011-10-28 2013-04-23 한국과학기술원 이중충하이드로젤 미세입자의 비등방성 부품을 이용한 미세수송체의 제조방법
US11565027B2 (en) 2012-12-11 2023-01-31 Board Of Regents, The University Of Texas System Hydrogel membrane for adhesion prevention
EP3505197B1 (de) 2012-12-11 2023-09-06 Board of Regents, The University of Texas System Hydrogelmembran zur anhaftungsverhinderung
US20150118300A1 (en) 2013-10-31 2015-04-30 Cima Labs Inc. Immediate Release Abuse-Deterrent Granulated Dosage Forms
US11426571B2 (en) * 2016-11-18 2022-08-30 Industry-Academic Cooperation Foundation, Yonsei University Microneedle array with composite formulation, and method for manufacturing same
US11980700B2 (en) 2017-03-08 2024-05-14 Alafair Biosciences, Inc. Hydrogel medium for the storage and preservation of tissue
KR102129986B1 (ko) * 2018-08-30 2020-07-03 포항공과대학교 산학협력단 일산화질소 감응성을 갖는 아크릴아마이드계 고분자를 포함하는 염증성 질환 예방 또는 치료용 약학 조성물
US10799564B1 (en) 2019-05-06 2020-10-13 Baxter International Inc. Insulin premix formulation and product, methods of preparing same, and methods of using same
US12589083B2 (en) 2019-05-07 2026-03-31 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine
US11324707B2 (en) 2019-05-07 2022-05-10 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine
GB201909280D0 (en) * 2019-06-27 2019-08-14 Enesi Pharma Ltd Solid dose formulation
KR102407470B1 (ko) * 2021-08-09 2022-06-10 인제대학교 산학협력단 하이드로겔에 담지된 약물의 방출량 검출 방법

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5036006A (en) * 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
JPH0725689B2 (ja) * 1986-10-07 1995-03-22 中外製薬株式会社 顆粒球コロニ−刺激因子を含有する徐放性製剤
SE456486B (sv) * 1987-03-27 1988-10-10 Ralf Andersson Sett och anordning for uppdelning av en smelta i droppar
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US4925677A (en) * 1988-08-31 1990-05-15 Theratech, Inc. Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
US5041292A (en) * 1988-08-31 1991-08-20 Theratech, Inc. Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
US5053332A (en) * 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
ES2113371T3 (es) 1989-11-16 1998-05-01 Univ Duke Transformacion de celulas epidermicas de tejidos animales con la ayuda de particulas.
DE59107006D1 (de) * 1990-04-25 1996-01-18 Hoechst Ag Pharmakologische Zubereitung, enthaltend Polyelektrolytkomplexe in mikropartikulärer Form und mindestens einen Wirkstoff.
GB9014871D0 (en) * 1990-07-05 1990-08-22 Erba Carlo Spa Drug delivery system for administering growth factor
WO1994009819A1 (en) 1992-11-03 1994-05-11 Secretech, Inc. Microcrystalline cellulose as an immune adjuvant
TW360548B (en) 1993-04-08 1999-06-11 Powderject Res Ltd Products for therapeutic use
DE69432867T2 (de) * 1993-11-18 2004-04-22 Sirtex Medical Ltd., Burswood Zubereitung mit gesteuerter freisetzung
GB9416663D0 (en) 1994-08-17 1994-10-12 Oxford Bioscience Limited Particle delivery
EP0788386B1 (de) 1994-10-24 1999-01-13 PowderJect Research Limited Nadellose spritze
GB9426379D0 (en) 1994-12-23 1995-03-01 Oxford Biosciences Ltd Particle delivery
GB9502879D0 (en) 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
GB9605690D0 (en) 1996-03-19 1996-05-22 Oxford Biosciences Ltd Particle delivery
GB9612629D0 (en) * 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
GB9619002D0 (en) * 1996-09-11 1996-10-23 Oxford Biosciences Ltd Particle delivery
AU4940197A (en) 1996-09-26 1998-04-17 Wanzl Metallwarenfabrik Gmbh Device and method for the purchasing of goods
US6656508B2 (en) * 1997-04-17 2003-12-02 Amgen Inc. Sustained-release alginate gels
EP0888790A1 (de) 1997-07-04 1999-01-07 PowderJect Research Limited Vorrichtung zur Abgabe von Medikamententeilchen
EP0888791A1 (de) 1997-07-04 1999-01-07 PowderJect Research Limited Spritze und dafür geeignete Medikamentenkapsel
WO2000014547A1 (en) 1998-09-04 2000-03-16 Powderject Research Limited Immunodiagnostics using particle delivery methods
JP2002524120A (ja) 1998-09-04 2002-08-06 パウダージェクト リサーチ リミテッド 粒子送達法を使用するモニタリング方法
US5952232A (en) * 1998-09-17 1999-09-14 Rothman; James Edward Expandible microparticle intracellular delivery system
IL142276A0 (en) 1998-10-01 2002-03-10 Powderject Res Ltd Spray coated microparticles for use in needleless syringes
EP1148902A1 (de) 1999-01-22 2001-10-31 PowderJect Research Limited Methode zur steigerung von nadelloser transdermaler medikamentenverabreichung in pulverform

Also Published As

Publication number Publication date
KR100845769B1 (ko) 2008-07-11
IL144597A (en) 2007-03-08
PT1146861E (pt) 2005-10-31
CN1345232A (zh) 2002-04-17
US20020061336A1 (en) 2002-05-23
DE60021059D1 (de) 2005-08-04
CA2361555A1 (en) 2000-08-10
KR20010101994A (ko) 2001-11-15
AU780397B2 (en) 2005-03-17
NZ513538A (en) 2004-02-27
IL144597A0 (en) 2002-05-23
BR0007974A (pt) 2001-10-30
EP1146861B1 (de) 2005-06-29
WO2000045792A1 (en) 2000-08-10
EP1146861A1 (de) 2001-10-24
JP2002536317A (ja) 2002-10-29
DE60021059T2 (de) 2006-05-18
MXPA01007844A (es) 2005-06-06
CN1230152C (zh) 2005-12-07
WO2000045792A8 (en) 2001-11-29
US7022313B2 (en) 2006-04-04
ES2243229T3 (es) 2005-12-01
AU2309200A (en) 2000-08-25

Similar Documents

Publication Publication Date Title
ATE298562T1 (de) Hydrogelpartikel formulierungen
ATE387430T1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
BR0308137A (pt) Formulações de droga de liberação constante contendo um peptìdeo veìculo
EP1015008A4 (de) Verbindungen und zusammensetzungen zur administration aktiver stoffe
ATE391708T1 (de) Verbindungen und gemische zur verabreichung eines aktiven agens
PL347671A1 (en) Compounds and compositions for delivering active agents
BR0107869A (pt) Composições farmacêuticas eletrogiradas
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
EP1478406A4 (de) Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
IL195055A0 (en) Phenoxy carboxylic acid compounds and compositions for delivering active agents
EP1100522A4 (de) Verabreichung aktiver wirkstoffe über die lunge
DE60312523D1 (de) Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit
ATE388687T1 (de) Medikamentöse verabreichung von nikotin in form von kaugummi
AU3492100A (en) Oxadiazole compounds and compositions for delivering active agents
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
ATE292453T1 (de) Antivirale arznei
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
TR200503846T2 (tr) Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı
CO5200854A1 (es) Formulaciones farmaceuticas orales en capsulas de gelatina de hidroxipropilmetil celulosa que comprenden un derivado de camptotecina dentro de una matriz semisolida de polietilenglicol
TR200200683T2 (tr) Oral kontrollü salıverme formülasyonları.
PT1144420E (pt) Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao
MX9702899A (es) Compuestos y composiciones para suministrar agentes activos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1146861

Country of ref document: EP

REN Ceased due to non-payment of the annual fee